US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Palisade Bio Inc.

2.01

-0.0900-4.29%

Post-market: 2.020.0100+0.50%16:58 EDT

Volume:1.61M

Turnover:3.31M

Market Cap:349.74M

PE:-9.98

High:2.10

Open:2.10

Low:2.00

Close:2.10

52wk High:2.86

52wk Low:0.5300

Shares:174.00M

Float Shares:130.00M

Volume Ratio:0.96

T/O Rate:1.24%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.2015

EPS(LYR):-0.3014

ROE:-51.37%

ROA:-32.98%

PB:2.87

PE(LYR):-6.67

Loading ...

Overview Company News Filings

Palisade Bio Wins FDA IND Clearance for Pali-2108 Ulcerative Colitis Trial

Palisade Bio - Ascentra-uc Enrollment Expected H2 2026; Primary Efficacy Results Expected H2 2027

THOMSON REUTERS

Palisade Bio - Expects to Submit Ind for Ascentra-cd in Crohn's Disease in H2 2026

THOMSON REUTERS

Palisade Bio Receives FDA Clearance of Ind for Pali-2108 and Plans to Initiate Global Phase 2 Ascentra-uc Study in Ulcerative Colitis

THOMSON REUTERS

Palisade Bio - Ascentra-uc Phase 2 Trial to Enroll up to 204 Patients in North America and Europe

THOMSON REUTERS

Palisade Bio director Robert Baltera Jr. files initial beneficial ownership statement

Palisade Bio director Jordan Michael Zwick files initial beneficial ownership statement (Form 3)

Palisade Bio raises authorized common shares to 450 million from 300 million

Palisade Bio adds Robert Baltera, Jordan Zwick to board of directors

Palisade Bio to Present on the Potential of PALI-2108 for Fibrostenotic Crohn’s Disease at New York Academy of Sciences Symposium

Palisade Bio (PALI) Gets a Buy from B. Riley Securities

Analysts Are Bullish on These Healthcare Stocks: BridgeBio Pharma (BBIO), Palisade Bio (PALI)

Palisade Bio Inc - May Offer and Sell up to $300 Mln of Securities - SEC Filing

THOMSON REUTERS

Palisade Bio Inc reports results for the quarter ended March 31 - Earnings Summary

Palisade Bio Q1 EPS $(0.05) Misses $(0.04) Estimate

Benzinga Earnings

Palisade Bio Q1 net loss widens on higher R&D costs

Palisade Bio plans Phase 2 ulcerative colitis trial of PALI-2108 in Q3 2026

BRIEF-Palisade Bio Q1 EPS USD -0.05

Palisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of Pali-2108

THOMSON REUTERS

Palisade Bio Q1 Operating Expenses USD 10.748 Million

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/PALI/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PALI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PALI\",,,,,undefined,":{"symbol":"PALI","market":"US","secType":"STK","nameCN":"Palisade Bio Inc.","latestPrice":2.01,"timestamp":1787601600000,"preClose":2.1,"halted":0,"volume":1613009,"hourTrading":{"tag":"盘后","latestPrice":2.02,"preClose":2.01,"latestTime":"16:58 EDT","volume":5217,"amount":10486.180434,"timestamp":1787605123927,"change":0.01,"changeRate":0.004975,"amplitude":0.004975},"delay":0,"changeRate":-0.042857142857142996,"floatShares":130000000,"shares":174000000,"eps":-0.201475,"marketStatus":"Post-Mkt","change":-0.09,"latestTime":"08-24 17:06:20 EDT","open":2.1,"high":2.1,"low":2,"amount":3309109.2552188,"amplitude":0.047619,"askPrice":2.09,"askSize":9,"bidPrice":2,"bidSize":250,"shortable":3,"etf":0,"ttmEps":-0.201475,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"listingDate":1188187200000,"exchange":"NASDAQ","adjPreClose":2.1,"preHourTrading":{"tag":"盘前","latestPrice":2.1,"preClose":2.1,"latestTime":"09:22 EDT","volume":440678,"amount":925434.6847466,"timestamp":1787577725736,"change":0,"changeRate":0,"amplitude":0.037143},"postHourTrading":{"tag":"盘后","latestPrice":2.02,"preClose":2.01,"latestTime":"16:58 EDT","volume":5217,"amount":10486.180434,"timestamp":1787605123927,"change":0.01,"changeRate":0.004975,"amplitude":0.004975},"volumeRatio":0.962903},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PALI\",,,,,undefined,":{"symbol":"PALI","floatShares":130000000,"roa":"-32.98%","roe":"-51.37%","lyrEps":-0.301438,"volumeRatio":0.962903,"shares":174000000,"dividePrice":0,"high":2.1,"amplitude":0.047619,"preClose":2.1,"low":2,"week52Low":0.53,"pbRate":"2.87","psRate":"699.48","week52High":2.855,"institutionHeld":0.9814,"latestPrice":2.01,"committee":0.930502,"eps":-0.201475,"divideRate":0,"volume":1613009,"delay":0,"ttmEps":-0.201475,"open":2.1,"prevYearClose":2.35,"prevWeekClose":2.1,"prevMonthClose":1.895,"prevQuarterClose":2.09,"fiveDayClose":2.15,"twentyDayClose":2.03,"sixtyDayClose":2.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PALI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"PALI","fiscalQuarterEnding":"2026/06","expectedEps":-0.05,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"post","actualEps":-0.05},{"market":"US","date":"2026-05-12","symbol":"PALI","fiscalQuarterEnding":"2026/03","expectedEps":-0.04,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.05},{"market":"US","date":"2026-03-20","symbol":"PALI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773979200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-10","symbol":"PALI","fiscalQuarterEnding":"2025/09","expectedEps":-0.32,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"post","actualEps":-0.38},{"market":"US","date":"2025-08-11","symbol":"PALI","fiscalQuarterEnding":"2025/06","expectedEps":-0.48,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"post","actualEps":-0.58}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PALI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PALI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":10,"updateTime":1784865600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PALI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PALI","date":"2026-08-21","current":-10.150143,"percent":0.176763,"low":-33.182614,"twenty":-1.111781,"median":-0.434072,"eighty":-0.268912,"high":5.714804,"avg":-3.731889,"sd":7.88063,"marketCap":358997349},"quantilePoints":[{"date":"2021-08-27","current":-0.68888,"twenty":-3.431237,"median":-2.990078,"eighty":-1.683951,"marketCap":28838584},{"date":"2021-09-03","current":-0.743337,"twenty":-3.431237,"median":-2.965569,"eighty":-1.659545,"marketCap":31118314},{"date":"2021-09-10","current":-0.816854,"twenty":-3.392023,"median":-2.932891,"eighty":-1.582669,"marketCap":34195950},{"date":"2021-09-17","current":-0.74606,"twenty":-3.375684,"median":-2.859364,"eighty":-1.503353,"marketCap":31232301},{"date":"2021-09-24","current":-0.658929,"twenty":-3.360979,"median":-2.373394,"eighty":-0.786902,"marketCap":27584733},{"date":"2021-10-01","current":-0.677989,"twenty":-3.351175,"median":-2.205609,"eighty":-0.760763,"marketCap":28382638},{"date":"2021-10-08","current":-0.756712,"twenty":-3.343006,"median":-2.123242,"eighty":-0.751505,"marketCap":31678255},{"date":"2021-10-15","current":-0.85246,"twenty":-3.3283,"median":-2.086634,"eighty":-0.753683,"marketCap":35686524},{"date":"2021-10-22","current":-0.80613,"twenty":-3.318497,"median":-2.056128,"eighty":-0.756215,"marketCap":33747039},{"date":"2021-10-29","current":-0.846283,"twenty":-3.303792,"median":-1.860887,"eighty":-0.76126,"marketCap":35427926},{"date":"2021-11-05","current":-0.880257,"twenty":-3.254774,"median":-1.683951,"eighty":-0.762791,"marketCap":36850215},{"date":"2021-11-12","current":-1.134957,"twenty":-3.236801,"median":-1.674799,"eighty":-0.764674,"marketCap":36242580},{"date":"2021-11-19","current":-1.045691,"twenty":-3.235167,"median":-1.659545,"eighty":-0.782546,"marketCap":33392040},{"date":"2021-11-26","current":-0.981929,"twenty":-3.220462,"median":-1.604634,"eighty":-0.786902,"marketCap":31355940},{"date":"2021-12-03","current":-0.786393,"twenty":-3.210658,"median":-1.558874,"eighty":-0.786902,"marketCap":25111900},{"date":"2021-12-10","current":-0.892663,"twenty":-3.210658,"median":-1.507014,"eighty":-0.786902,"marketCap":28505400},{"date":"2021-12-17","current":-0.807647,"twenty":-3.195953,"median":-1.139207,"eighty":-0.786902,"marketCap":25790600},{"date":"2021-12-23","current":-0.709879,"twenty":-3.179613,"median":-1.06907,"eighty":-0.786393,"marketCap":22668580},{"date":"2021-12-31","current":-0.552601,"twenty":-3.146935,"median":-0.994681,"eighty":-0.758986,"marketCap":17646200},{"date":"2022-01-07","current":-0.565353,"twenty":-3.109355,"median":-0.984055,"eighty":-0.751505,"marketCap":18053420},{"date":"2022-01-14","current":-0.552601,"twenty":-3.101185,"median":-0.973427,"eighty":-0.743337,"marketCap":17646200},{"date":"2022-01-21","current":-0.448457,"twenty":-3.094649,"median":-0.914232,"eighty":-0.729723,"marketCap":14320570},{"date":"2022-01-28","current":-0.467585,"twenty":-3.088114,"median":-0.892637,"eighty":-0.708328,"marketCap":14931400},{"date":"2022-02-04","current":-0.393367,"twenty":-3.084846,"median":-0.884161,"eighty":-0.689425,"marketCap":12561379},{"date":"2022-02-11","current":-0.429328,"twenty":-3.068506,"median":-0.872535,"eighty":-0.671031,"marketCap":13709740},{"date":"2022-02-18","current":-0.403016,"twenty":-3.042364,"median":-0.855548,"eighty":-0.659474,"marketCap":12869509},{"date":"2022-02-25","current":-0.391071,"twenty":-2.990078,"median":-0.850155,"eighty":-0.641867,"marketCap":12488080},{"date":"2022-03-04","current":-0.393154,"twenty":-2.990078,"median":-0.849371,"eighty":-0.599359,"marketCap":12554592},{"date":"2022-03-11","current":-0.442081,"twenty":-2.990078,"median":-0.849371,"eighty":-0.582356,"marketCap":14116960},{"date":"2022-03-18","current":-0.602849,"twenty":-2.965569,"median":-0.844549,"eighty":-0.565353,"marketCap":16045436},{"date":"2022-03-25","current":-0.801515,"twenty":-2.965569,"median":-0.837017,"eighty":-0.565353,"marketCap":21333136},{"date":"2022-04-01","current":-0.712458,"twenty":-2.932891,"median":-0.829295,"eighty":-0.573855,"marketCap":18962788},{"date":"2022-04-08","current":-0.650735,"twenty":-2.883873,"median":-0.816854,"eighty":-0.582356,"marketCap":17319954},{"date":"2022-04-14","current":-0.637102,"twenty":-2.870802,"median":-0.811898,"eighty":-0.585757,"marketCap":16957108},{"date":"2022-04-22","current":-0.615317,"twenty":-2.854463,"median":-0.806889,"eighty":-0.593409,"marketCap":16377284},{"date":"2022-04-29","current":-0.534344,"twenty":-2.831588,"median":-0.794895,"eighty":-0.573762,"marketCap":14222091},{"date":"2022-05-06","current":-0.422789,"twenty":-2.464052,"median":-0.788264,"eighty":-0.559402,"marketCap":11252961},{"date":"2022-05-13","current":-0.412841,"twenty":-2.329465,"median":-0.786902,"eighty":-0.547771,"marketCap":11060415},{"date":"2022-05-20","current":-0.424683,"twenty":-2.235505,"median":-0.786393,"eighty":-0.513494,"marketCap":11377678},{"date":"2022-05-27","current":-0.418149,"twenty":-2.200118,"median":-0.76512,"eighty":-0.503186,"marketCap":11202636},{"date":"2022-06-03","current":-0.444937,"twenty":-2.152528,"median":-0.762397,"eighty":-0.476087,"marketCap":11920305},{"date":"2022-06-10","current":-0.438567,"twenty":-2.123242,"median":-0.758562,"eighty":-0.466914,"marketCap":11749640},{"date":"2022-06-17","current":-0.367514,"twenty":-2.11226,"median":-0.754228,"eighty":-0.451634,"marketCap":9846067},{"date":"2022-06-24","current":-0.366126,"twenty":-2.102498,"median":-0.751505,"eighty":-0.445495,"marketCap":9808871},{"date":"2022-07-01","current":-0.325781,"twenty":-2.089075,"median":-0.746385,"eighty":-0.44007,"marketCap":8727991},{"date":"2022-07-08","current":-0.400264,"twenty":-2.071991,"median":-0.743612,"eighty":-0.43499,"marketCap":10723461},{"date":"2022-07-15","current":-0.383848,"twenty":-2.061009,"median":-0.737891,"eighty":-0.428094,"marketCap":10283670},{"date":"2022-07-22","current":-0.363839,"twenty":-2.043925,"median":-0.728361,"eighty":-0.424683,"marketCap":9747606},{"date":"2022-07-29","current":-0.315572,"twenty":-1.981692,"median":-0.721554,"eighty":-0.420835,"marketCap":8454489},{"date":"2022-08-05","current":-0.423458,"twenty":-1.901155,"median":-0.712458,"eighty":-0.418084,"marketCap":11344857},{"date":"2022-08-12","current":-0.570101,"twenty":-1.792553,"median":-0.709879,"eighty":-0.416508,"marketCap":15273575},{"date":"2022-08-19","current":4.414871,"twenty":-1.766928,"median":-0.701936,"eighty":-0.411475,"marketCap":11527227},{"date":"2022-08-26","current":4.512979,"twenty":-1.683951,"median":-0.68888,"eighty":-0.405749,"marketCap":11783387},{"date":"2022-09-02","current":4.029939,"twenty":-1.682731,"median":-0.683343,"eighty":-0.400558,"marketCap":10522170},{"date":"2022-09-09","current":4.038124,"twenty":-1.677849,"median":-0.676931,"eighty":-0.398303,"marketCap":10543542},{"date":"2022-09-16","current":3.819847,"twenty":-1.671748,"median":-0.667097,"eighty":-0.394592,"marketCap":9973621},{"date":"2022-09-23","current":3.113175,"twenty":-1.671748,"median":-0.660291,"eighty":-0.391921,"marketCap":8128501},{"date":"2022-09-30","current":2.701177,"twenty":-1.659545,"median":-0.650735,"eighty":-0.39079,"marketCap":7052774},{"date":"2022-10-07","current":2.709363,"twenty":-1.647343,"median":-0.642122,"eighty":-0.38563,"marketCap":7074146},{"date":"2022-10-14","current":2.589311,"twenty":-1.604634,"median":-0.637102,"eighty":-0.373068,"marketCap":6760690},{"date":"2022-10-21","current":2.837601,"twenty":-1.58633,"median":-0.630286,"eighty":-0.367514,"marketCap":7408975},{"date":"2022-10-28","current":2.589311,"twenty":-1.568026,"median":-0.61381,"eighty":-0.365524,"marketCap":6760690},{"date":"2022-11-04","current":2.335563,"twenty":-1.549723,"median":-0.605735,"eighty":-0.361316,"marketCap":6098156},{"date":"2022-11-11","current":2.23461,"twenty":-1.53752,"median":-0.602301,"eighty":-0.35118,"marketCap":5834568},{"date":"2022-11-18","current":-0.398957,"twenty":-1.507014,"median":-0.597644,"eighty":-0.35538,"marketCap":3776927},{"date":"2022-11-25","current":-0.610649,"twenty":-1.492371,"median":-0.60083,"eighty":-0.357408,"marketCap":5781011},{"date":"2022-12-02","current":-0.69044,"twenty":-1.212508,"median":-0.602849,"eighty":-0.359061,"marketCap":6536396},{"date":"2022-12-09","current":-0.498289,"twenty":-1.136657,"median":-0.60083,"eighty":-0.35977,"marketCap":4717305},{"date":"2022-12-16","current":-0.381045,"twenty":-1.083947,"median":-0.59593,"eighty":-0.361028,"marketCap":3607351},{"date":"2022-12-23","current":-0.311024,"twenty":-1.067795,"median":-0.594423,"eighty":-0.354976,"marketCap":2944461},{"date":"2022-12-30","current":-0.846766,"twenty":-1.054193,"median":-0.590172,"eighty":-0.352489,"marketCap":8016335},{"date":"2023-01-06","current":-0.785441,"twenty":-1.058443,"median":-0.595109,"eighty":-0.354169,"marketCap":7435768},{"date":"2023-01-13","current":-1.118311,"twenty":-1.058443,"median":-0.597622,"eighty":-0.356394,"marketCap":10587051},{"date":"2023-01-20","current":-0.996847,"twenty":-1.067829,"median":-0.602301,"eighty":-0.358201,"marketCap":9437147},{"date":"2023-01-27","current":-0.938209,"twenty":-1.066328,"median":-0.605735,"eighty":-0.359453,"marketCap":8882021},{"date":"2023-02-03","current":-1.143442,"twenty":-1.078731,"median":-0.610649,"eighty":-0.360164,"marketCap":10824963},{"date":"2023-02-10","current":-0.967528,"twenty":-1.070566,"median":-0.618682,"eighty":-0.361739,"marketCap":9159584},{"date":"2023-02-17","current":-0.967528,"twenty":-1.067829,"median":-0.630252,"eighty":-0.363512,"marketCap":9159584},{"date":"2023-02-24","current":-0.904701,"twenty":-1.066945,"median":-0.631818,"eighty":-0.363839,"marketCap":8564806},{"date":"2023-03-03","current":-0.900513,"twenty":-1.063862,"median":-0.637102,"eighty":-0.363839,"marketCap":8525154},{"date":"2023-03-10","current":-0.846063,"twenty":-1.045691,"median":-0.641867,"eighty":-0.365524,"marketCap":8009679},{"date":"2023-03-17","current":-0.795802,"twenty":-1.030354,"median":-0.647255,"eighty":-0.365881,"marketCap":7533857},{"date":"2023-03-24","current":-0.517989,"twenty":-1.005224,"median":-0.646473,"eighty":-0.365962,"marketCap":7386522},{"date":"2023-03-31","current":-1.111781,"twenty":-1.005224,"median":-0.644425,"eighty":-0.366126,"marketCap":15853999},{"date":"2023-04-06","current":-0.688546,"twenty":-1.01025,"median":-0.647255,"eighty":-0.367236,"marketCap":9818669},{"date":"2023-04-14","current":-0.713644,"twenty":-1.001873,"median":-0.652987,"eighty":-0.368102,"marketCap":10176564},{"date":"2023-04-21","current":-0.654174,"twenty":-1.001035,"median":-0.65541,"eighty":-0.369295,"marketCap":9328517},{"date":"2023-04-28","current":-0.737945,"twenty":-1.001035,"median":-0.654615,"eighty":-0.371189,"marketCap":10523092},{"date":"2023-05-05","current":-0.628469,"twenty":-0.997685,"median":-0.65541,"eighty":-0.372642,"marketCap":8961974},{"date":"2023-05-12","current":-0.656852,"twenty":-0.995114,"median":-0.654615,"eighty":-0.373035,"marketCap":9366708},{"date":"2023-05-19","current":-0.732361,"twenty":-0.993063,"median":-0.656852,"eighty":-0.374309,"marketCap":9077612},{"date":"2023-05-25","current":-0.676384,"twenty":-0.991322,"median":-0.659918,"eighty":-0.377706,"marketCap":8383782},{"date":"2023-06-02","current":-0.778028,"twenty":-0.988731,"median":-0.663013,"eighty":-0.380276,"marketCap":9643654},{"date":"2023-06-09","current":-0.869878,"twenty":-0.98448,"median":-0.667097,"eighty":-0.382166,"marketCap":10782141},{"date":"2023-06-15","current":-0.875281,"twenty":-0.981929,"median":-0.67307,"eighty":-0.384204,"marketCap":10849110},{"date":"2023-06-23","current":-0.923908,"twenty":-0.981929,"median":-0.674471,"eighty":-0.385274,"marketCap":11451839},{"date":"2023-06-30","current":-0.864475,"twenty":-0.980827,"median":-0.677186,"eighty":-0.386075,"marketCap":10715171},{"date":"2023-07-07","current":-0.950923,"twenty":-0.97876,"median":-0.681631,"eighty":-0.386553,"marketCap":11786688},{"date":"2023-07-14","current":-1.102206,"twenty":-0.981929,"median":-0.685714,"eighty":-0.387278,"marketCap":13661843},{"date":"2023-07-21","current":-1.085997,"twenty":-0.98788,"median":-0.687352,"eighty":-0.387446,"marketCap":13460933},{"date":"2023-07-28","current":-1.167042,"twenty":-0.998522,"median":-0.69044,"eighty":-0.387685,"marketCap":14465481},{"date":"2023-08-04","current":-1.123818,"twenty":-1.015276,"median":-0.695051,"eighty":-0.389582,"marketCap":13929722},{"date":"2023-08-11","current":-0.372805,"twenty":-1.046685,"median":-0.69506,"eighty":-0.389582,"marketCap":4620917},{"date":"2023-08-18","current":-0.316168,"twenty":-1.036489,"median":-0.691021,"eighty":-0.386075,"marketCap":4250561},{"date":"2023-08-25","current":-0.316168,"twenty":-1.015276,"median":-0.688546,"eighty":-0.377706,"marketCap":4250561},{"date":"2023-09-01","current":-0.347683,"twenty":-1.002711,"median":-0.685385,"eighty":-0.372322,"marketCap":4674246},{"date":"2023-09-08","current":-0.397658,"twenty":-1.001035,"median":-0.683343,"eighty":-0.370372,"marketCap":5346109},{"date":"2023-09-15","current":-0.424944,"twenty":-1.001035,"median":-0.677186,"eighty":-0.371839,"marketCap":5712941},{"date":"2023-09-19","current":-0.414479,"twenty":-1.001035,"median":-0.676384,"eighty":-0.37208,"marketCap":5572256},{"date":"2023-09-29","current":-0.368654,"twenty":-1.001035,"median":-0.674471,"eighty":-0.368654,"marketCap":4956181},{"date":"2023-10-06","current":-0.39054,"twenty":-0.996847,"median":-0.66982,"eighty":-0.369556,"marketCap":5250426},{"date":"2023-10-13","current":-0.378092,"twenty":-0.995114,"median":-0.666828,"eighty":-0.371189,"marketCap":5083074},{"date":"2023-10-17","current":-0.411059,"twenty":-0.994276,"median":-0.664374,"eighty":-0.371839,"marketCap":5526280},{"date":"2023-11-02","current":-0.376177,"twenty":-0.993063,"median":-0.66128,"eighty":-0.372563,"marketCap":5057328},{"date":"2023-11-10","current":-0.355659,"twenty":-0.990876,"median":-0.656852,"eighty":-0.371023,"marketCap":4781473},{"date":"2023-11-17","current":-0.36942,"twenty":-0.98703,"median":-0.65541,"eighty":-0.369529,"marketCap":4820558},{"date":"2023-11-24","current":-0.413213,"twenty":-0.98448,"median":-0.654174,"eighty":-0.370164,"marketCap":5392020},{"date":"2023-12-01","current":-0.441467,"twenty":-0.981929,"median":-0.652797,"eighty":-0.371138,"marketCap":5760705},{"date":"2023-12-08","current":-0.431578,"twenty":-0.981562,"median":-0.649739,"eighty":-0.371431,"marketCap":5631665},{"date":"2023-12-15","current":-0.416816,"twenty":-0.97876,"median":-0.646473,"eighty":-0.371839,"marketCap":5439027},{"date":"2023-12-22","current":-0.420347,"twenty":-0.973249,"median":-0.644586,"eighty":-0.372825,"marketCap":5485113},{"date":"2023-12-29","current":-0.461881,"twenty":-0.972713,"median":-0.642377,"eighty":-0.372883,"marketCap":6027080},{"date":"2024-01-05","current":-0.385997,"twenty":-0.972207,"median":-0.641518,"eighty":-0.372969,"marketCap":5036876},{"date":"2024-01-12","current":-0.376548,"twenty":-0.970041,"median":-0.637102,"eighty":-0.373217,"marketCap":4913573},{"date":"2024-01-19","current":-0.376548,"twenty":-0.967528,"median":-0.633446,"eighty":-0.373143,"marketCap":4913573},{"date":"2024-01-26","current":-0.363049,"twenty":-0.96669,"median":-0.630286,"eighty":-0.372825,"marketCap":4737426},{"date":"2024-02-02","current":-0.416981,"twenty":-0.962806,"median":-0.628469,"eighty":-0.372825,"marketCap":5441185},{"date":"2024-02-09","current":-0.319738,"twenty":-0.96037,"median":-0.623231,"eighty":-0.371427,"marketCap":4172255},{"date":"2024-02-16","current":-0.314051,"twenty":-0.957505,"median":-0.61381,"eighty":-0.369425,"marketCap":4098049},{"date":"2024-02-23","current":-0.300332,"twenty":-0.950923,"median":-0.60922,"eighty":-0.368249,"marketCap":3919026},{"date":"2024-03-01","current":-0.285759,"twenty":-0.94552,"median":-0.603229,"eighty":-0.365962,"marketCap":3728872},{"date":"2024-03-08","current":-0.278224,"twenty":-0.942397,"median":-0.599359,"eighty":-0.363839,"marketCap":3630548},{"date":"2024-03-15","current":-0.261235,"twenty":-0.940117,"median":-0.595519,"eighty":-0.363404,"marketCap":3408857},{"date":"2024-03-22","current":-0.277087,"twenty":-0.938209,"median":-0.593738,"eighty":-0.36253,"marketCap":3615707},{"date":"2024-03-28","current":-0.410438,"twenty":-0.938209,"median":-0.582356,"eighty":-0.361028,"marketCap":5048382},{"date":"2024-04-05","current":-0.398186,"twenty":-0.938209,"median":-0.571746,"eighty":-0.361914,"marketCap":4897684},{"date":"2024-04-12","current":-0.303182,"twenty":-0.931507,"median":-0.565353,"eighty":-0.361028,"marketCap":3729136},{"date":"2024-04-19","current":-0.350943,"twenty":-0.929832,"median":-0.559354,"eighty":-0.359061,"marketCap":4316603},{"date":"2024-04-26","current":-0.431238,"twenty":-0.929832,"median":-0.552601,"eighty":-0.357464,"marketCap":5304228},{"date":"2024-05-03","current":-0.504611,"twenty":-0.929832,"median":-0.549758,"eighty":-0.359061,"marketCap":6206713},{"date":"2024-05-10","current":-0.480384,"twenty":-0.929415,"median":-0.546835,"eighty":-0.35977,"marketCap":5908722},{"date":"2024-05-17","current":-0.407804,"twenty":-0.929311,"median":-0.543164,"eighty":-0.361028,"marketCap":5500050},{"date":"2024-05-24","current":-0.358259,"twenty":-0.924989,"median":-0.534344,"eighty":-0.35977,"marketCap":4831834},{"date":"2024-05-31","current":-0.320072,"twenty":-0.923908,"median":-0.527464,"eighty":-0.358121,"marketCap":4316813},{"date":"2024-06-07","current":-0.325627,"twenty":-0.918102,"median":-0.520417,"eighty":-0.352702,"marketCap":4391725},{"date":"2024-06-14","current":-0.315212,"twenty":-0.913389,"median":-0.514587,"eighty":-0.349811,"marketCap":4251265},{"date":"2024-06-21","current":-0.330487,"twenty":-0.911478,"median":-0.507968,"eighty":-0.342356,"marketCap":4457273},{"date":"2024-06-28","current":-0.317295,"twenty":-0.910184,"median":-0.505842,"eighty":-0.339575,"marketCap":4279357},{"date":"2024-07-05","current":-0.30202,"twenty":-0.907214,"median":-0.504098,"eighty":-0.335275,"marketCap":4073348},{"date":"2024-07-12","current":-0.31174,"twenty":-0.904701,"median":-0.501591,"eighty":-0.330597,"marketCap":4204444},{"date":"2024-07-15","current":-0.315212,"twenty":-0.904701,"median":-0.49994,"eighty":-0.330487,"marketCap":4251265},{"date":"2024-08-02","current":-0.253419,"twenty":-0.904701,"median":-0.498289,"eighty":-0.329742,"marketCap":3417867},{"date":"2024-08-09","current":-0.252725,"twenty":-0.902443,"median":-0.487711,"eighty":-0.32575,"marketCap":3408503},{"date":"2024-08-16","current":-0.310036,"twenty":-0.900786,"median":-0.476087,"eighty":-0.322579,"marketCap":4394446},{"date":"2024-08-23","current":-0.300008,"twenty":-0.900513,"median":-0.47231,"eighty":-0.321132,"marketCap":4252308},{"date":"2024-08-30","current":-0.300843,"twenty":-0.897617,"median":-0.467585,"eighty":-0.319624,"marketCap":4264153},{"date":"2024-09-06","current":-0.306693,"twenty":-0.894355,"median":-0.465907,"eighty":-0.318303,"marketCap":4347067},{"date":"2024-09-13","current":-0.311707,"twenty":-0.892632,"median":-0.462608,"eighty":-0.317049,"marketCap":4418136},{"date":"2024-09-20","current":-0.320064,"twenty":-0.892326,"median":-0.459208,"eighty":-0.317065,"marketCap":4536585},{"date":"2024-09-27","current":-0.281623,"twenty":-0.890568,"median":-0.455058,"eighty":-0.316168,"marketCap":3991721},{"date":"2024-10-04","current":-0.297501,"twenty":-0.888577,"median":-0.448457,"eighty":-0.315212,"marketCap":4216773},{"date":"2024-10-11","current":-0.290815,"twenty":-0.887947,"median":-0.444099,"eighty":-0.313361,"marketCap":4122014},{"date":"2024-10-18","current":-0.298336,"twenty":-0.885675,"median":-0.442122,"eighty":-0.312157,"marketCap":4228618},{"date":"2024-10-25","current":-0.289144,"twenty":-0.881819,"median":-0.442081,"eighty":-0.31174,"marketCap":4098325},{"date":"2024-10-31","current":-0.259059,"twenty":-0.880257,"median":-0.44122,"eighty":-0.311068,"marketCap":3671909},{"date":"2024-11-08","current":-0.212262,"twenty":-0.878267,"median":-0.439544,"eighty":-0.310352,"marketCap":3008596},{"date":"2024-11-15","current":-0.220644,"twenty":-0.87312,"median":-0.438648,"eighty":-0.309383,"marketCap":3103355},{"date":"2024-11-22","current":-0.230645,"twenty":-0.869878,"median":-0.434565,"eighty":-0.307597,"marketCap":3244019},{"date":"2024-11-29","current":-0.232535,"twenty":-0.868865,"median":-0.433153,"eighty":-0.30673,"marketCap":3270609},{"date":"2024-12-06","current":-0.165421,"twenty":-0.864746,"median":-0.431408,"eighty":-0.304339,"marketCap":2326653},{"date":"2024-12-13","current":-0.223083,"twenty":-0.864475,"median":-0.429318,"eighty":-0.30202,"marketCap":3137657},{"date":"2024-12-20","current":-0.170148,"twenty":-0.864475,"median":-0.427619,"eighty":-0.300848,"marketCap":2393128},{"date":"2024-12-27","current":-0.167312,"twenty":-0.864475,"median":-0.427376,"eighty":-0.300008,"marketCap":2353243},{"date":"2025-01-03","current":-0.175819,"twenty":-0.862276,"median":-0.425615,"eighty":-0.298713,"marketCap":2472899},{"date":"2025-01-10","current":-0.189998,"twenty":-0.858019,"median":-0.424813,"eighty":-0.297501,"marketCap":2672327},{"date":"2025-01-17","current":-0.156914,"twenty":-0.853695,"median":-0.424683,"eighty":-0.296397,"marketCap":2206996},{"date":"2025-01-24","current":-0.139899,"twenty":-0.851577,"median":-0.423458,"eighty":-0.29497,"marketCap":1967683},{"date":"2025-01-31","current":-0.281219,"twenty":-0.850213,"median":-0.422628,"eighty":-0.294391,"marketCap":3955351},{"date":"2025-02-07","current":-0.255654,"twenty":-0.850155,"median":-0.421689,"eighty":-0.291697,"marketCap":3595774},{"date":"2025-02-14","current":-0.202557,"twenty":-0.849841,"median":-0.420673,"eighty":-0.288648,"marketCap":2848959},{"date":"2025-02-21","current":-0.192724,"twenty":-0.849371,"median":-0.420347,"eighty":-0.287568,"marketCap":2710660},{"date":"2025-02-28","current":-0.162045,"twenty":-0.849371,"median":-0.418149,"eighty":-0.286746,"marketCap":2279167},{"date":"2025-03-07","current":-0.164602,"twenty":-0.849371,"median":-0.417423,"eighty":-0.2853,"marketCap":2315125},{"date":"2025-03-14","current":-0.180433,"twenty":-0.84915,"median":-0.416981,"eighty":-0.283159,"marketCap":2537786},{"date":"2025-03-21","current":-0.154081,"twenty":-0.847966,"median":-0.416696,"eighty":-0.281643,"marketCap":2167145},{"date":"2025-03-28","current":-0.209966,"twenty":-0.846669,"median":-0.415332,"eighty":-0.281219,"marketCap":3031487},{"date":"2025-04-04","current":-0.19611,"twenty":-0.846239,"median":-0.413798,"eighty":-0.278423,"marketCap":2831440},{"date":"2025-04-11","current":-0.207073,"twenty":-0.846031,"median":-0.412841,"eighty":-0.273332,"marketCap":2989719},{"date":"2025-04-17","current":-0.213255,"twenty":-0.845904,"median":-0.412325,"eighty":-0.26877,"marketCap":3078975},{"date":"2025-04-25","current":-0.223974,"twenty":-0.843194,"median":-0.411077,"eighty":-0.265745,"marketCap":3233733},{"date":"2025-05-02","current":-0.237708,"twenty":-0.842863,"median":-0.410438,"eighty":-0.261235,"marketCap":3432021},{"date":"2025-05-09","current":-0.232927,"twenty":-0.841653,"median":-0.409293,"eighty":-0.256637,"marketCap":3362994},{"date":"2025-05-16","current":-0.227545,"twenty":-0.837686,"median":-0.408074,"eighty":-0.254212,"marketCap":2990163},{"date":"2025-05-23","current":-0.253106,"twenty":-0.837017,"median":-0.406762,"eighty":-0.253106,"marketCap":3326062},{"date":"2025-05-30","current":-0.229953,"twenty":-0.836999,"median":-0.405958,"eighty":-0.25303,"marketCap":3021814},{"date":"2025-06-06","current":-0.248267,"twenty":-0.834541,"median":-0.404031,"eighty":-0.25303,"marketCap":3262477},{"date":"2025-06-13","current":-0.251807,"twenty":-0.833584,"median":-0.403377,"eighty":-0.251713,"marketCap":3308995},{"date":"2025-06-20","current":-0.233743,"twenty":-0.832633,"median":-0.402244,"eighty":-0.248442,"marketCap":3071611},{"date":"2025-06-27","current":-0.260493,"twenty":-0.831326,"median":-0.40021,"eighty":-0.248442,"marketCap":3423132},{"date":"2025-07-03","current":-0.26458,"twenty":-0.830227,"median":-0.398957,"eighty":-0.248384,"marketCap":3476843},{"date":"2025-07-11","current":-0.284651,"twenty":-0.828686,"median":-0.398125,"eighty":-0.249392,"marketCap":3740603},{"date":"2025-07-18","current":-0.272243,"twenty":-0.826515,"median":-0.397044,"eighty":-0.25092,"marketCap":3577551},{"date":"2025-07-25","current":-0.405081,"twenty":-0.821539,"median":-0.396608,"eighty":-0.251524,"marketCap":5323167},{"date":"2025-08-01","current":-0.372236,"twenty":-0.815036,"median":-0.397044,"eighty":-0.252174,"marketCap":4891558},{"date":"2025-08-08","current":-0.395461,"twenty":-0.812144,"median":-0.395817,"eighty":-0.252877,"marketCap":5196747},{"date":"2025-08-15","current":-0.627447,"twenty":-0.810198,"median":-0.395461,"eighty":-0.253231,"marketCap":7432108},{"date":"2025-08-22","current":-0.558928,"twenty":-0.807647,"median":-0.397351,"eighty":-0.253697,"marketCap":6620504},{"date":"2025-08-29","current":-0.523052,"twenty":-0.80704,"median":-0.398064,"eighty":-0.254153,"marketCap":6195551},{"date":"2025-09-05","current":-0.487099,"twenty":-0.805913,"median":-0.398303,"eighty":-0.25422,"marketCap":5769687},{"date":"2025-09-12","current":-0.448066,"twenty":-0.80487,"median":-0.400115,"eighty":-0.254324,"marketCap":5307346},{"date":"2025-09-19","current":-0.460384,"twenty":-0.803646,"median":-0.401734,"eighty":-0.25465,"marketCap":5453252},{"date":"2025-09-26","current":-0.595112,"twenty":-0.801115,"median":-0.403377,"eighty":-0.254938,"marketCap":7049104},{"date":"2025-10-03","current":-1.308785,"twenty":-0.803646,"median":-0.404031,"eighty":-0.255496,"marketCap":15502558},{"date":"2025-10-10","current":-17.134268,"twenty":-0.807647,"median":-0.405375,"eighty":-0.255717,"marketCap":202955405},{"date":"2025-10-17","current":-14.115373,"twenty":-0.8231,"median":-0.406668,"eighty":-0.255997,"marketCap":167196595},{"date":"2025-10-24","current":-14.44174,"twenty":-0.831813,"median":-0.407939,"eighty":-0.256145,"marketCap":171062412},{"date":"2025-10-31","current":-21.783452,"twenty":-0.837012,"median":-0.408905,"eighty":-0.256335,"marketCap":258024989},{"date":"2025-11-07","current":-18.639449,"twenty":-0.843128,"median":-0.410109,"eighty":-0.256874,"marketCap":220784269},{"date":"2025-11-14","current":-22.155248,"twenty":-0.846669,"median":-0.411059,"eighty":-0.257837,"marketCap":248714809},{"date":"2025-11-21","current":-31.058927,"twenty":-0.849371,"median":-0.411794,"eighty":-0.258027,"marketCap":348667511},{"date":"2025-11-28","current":-28.006126,"twenty":-0.850155,"median":-0.412678,"eighty":-0.258558,"marketCap":314396773},{"date":"2025-12-05","current":-23.891482,"twenty":-0.861726,"median":-0.413213,"eighty":-0.259059,"marketCap":268205778},{"date":"2025-12-12","current":-29.2007,"twenty":-0.864814,"median":-0.41472,"eighty":-0.260493,"marketCap":327807062},{"date":"2025-12-19","current":-22.165986,"twenty":-0.880257,"median":-0.416491,"eighty":-0.260967,"marketCap":248835360},{"date":"2025-12-26","current":-29.2007,"twenty":-0.887947,"median":-0.416816,"eighty":-0.261181,"marketCap":327807062},{"date":"2026-01-02","current":-31.191657,"twenty":-0.892326,"median":-0.416981,"eighty":-0.261426,"marketCap":350157543},{"date":"2026-01-09","current":-25.218787,"twenty":-0.900513,"median":-0.417423,"eighty":-0.261727,"marketCap":283106099},{"date":"2026-01-16","current":-23.22783,"twenty":-0.906377,"median":-0.418149,"eighty":-0.262544,"marketCap":260755617},{"date":"2026-01-23","current":-24.555134,"twenty":-0.920038,"median":-0.420347,"eighty":-0.263055,"marketCap":275655938},{"date":"2026-01-30","current":-21.369603,"twenty":-0.929624,"median":-0.420673,"eighty":-0.263704,"marketCap":239895168},{"date":"2026-02-06","current":-19.909568,"twenty":-0.934858,"median":-0.421689,"eighty":-0.26458,"marketCap":223504815},{"date":"2026-02-13","current":-23.095099,"twenty":-0.941485,"median":-0.422628,"eighty":-0.264682,"marketCap":259265585},{"date":"2026-02-20","current":-21.635064,"twenty":-0.957505,"median":-0.423311,"eighty":-0.264965,"marketCap":242875232},{"date":"2026-02-27","current":-24.555134,"twenty":-0.967528,"median":-0.423808,"eighty":-0.265539,"marketCap":275655938},{"date":"2026-03-06","current":-21.767795,"twenty":-0.97876,"median":-0.424683,"eighty":-0.265767,"marketCap":244365264},{"date":"2026-03-13","current":-26.944283,"twenty":-0.989581,"median":-0.425078,"eighty":-0.26587,"marketCap":302476516},{"date":"2026-03-20","current":-26.413361,"twenty":-1.000197,"median":-0.427376,"eighty":-0.266232,"marketCap":296516387},{"date":"2026-03-27","current":-19.375141,"twenty":-1.007872,"median":-0.427777,"eighty":-0.267535,"marketCap":325134241},{"date":"2026-04-02","current":-18.584319,"twenty":-1.048176,"median":-0.429318,"eighty":-0.267864,"marketCap":311863455},{"date":"2026-04-10","current":-19.754184,"twenty":-1.066945,"median":-0.431183,"eighty":-0.268594,"marketCap":331494969},{"date":"2026-04-17","current":-23.246086,"twenty":-1.085997,"median":-0.43285,"eighty":-0.26877,"marketCap":390092565},{"date":"2026-04-24","current":-21.650111,"twenty":-1.111781,"median":-0.434072,"eighty":-0.268912,"marketCap":363310518},{"date":"2026-05-01","current":-19.95402,"twenty":-1.121615,"median":-0.435627,"eighty":-0.269184,"marketCap":334848404},{"date":"2026-05-08","current":-19.85425,"twenty":-1.121615,"median":-0.435627,"eighty":-0.269184,"marketCap":333174161},{"date":"2026-05-15","current":-12.54763,"twenty":-1.121615,"median":-0.435627,"eighty":-0.269184,"marketCap":303037805},{"date":"2026-05-22","current":-13.934108,"twenty":-1.121615,"median":-0.435627,"eighty":-0.269184,"marketCap":336522646},{"date":"2026-05-29","current":-14.280728,"twenty":-1.117005,"median":-0.434565,"eighty":-0.269048,"marketCap":344893856},{"date":"2026-06-05","current":-13.379517,"twenty":-1.121615,"median":-0.435627,"eighty":-0.269184,"marketCap":323128709},{"date":"2026-06-12","current":-12.339658,"twenty":-1.121615,"median":-0.435627,"eighty":-0.269184,"marketCap":298015079},{"date":"2026-06-18","current":-12.20101,"twenty":-1.121615,"median":-0.435627,"eighty":-0.269184,"marketCap":294666595},{"date":"2026-06-26","current":-12.937079,"twenty":-1.117005,"median":-0.434565,"eighty":-0.269048,"marketCap":312443406},{"date":"2026-07-02","current":-14.158915,"twenty":-1.117005,"median":-0.434565,"eighty":-0.269048,"marketCap":341951949},{"date":"2026-07-10","current":-14.158915,"twenty":-1.117005,"median":-0.434565,"eighty":-0.269048,"marketCap":341951949},{"date":"2026-07-17","current":-13.583933,"twenty":-1.117005,"median":-0.434565,"eighty":-0.269048,"marketCap":328065576},{"date":"2026-07-24","current":-14.518278,"twenty":-1.117005,"median":-0.434565,"eighty":-0.269048,"marketCap":350630933},{"date":"2026-07-31","current":-14.087042,"twenty":-1.111781,"median":-0.434072,"eighty":-0.268912,"marketCap":340216153},{"date":"2026-08-07","current":-15.021387,"twenty":-1.111781,"median":-0.434072,"eighty":-0.268912,"marketCap":362781510},{"date":"2026-08-14","current":-11.730431,"twenty":-1.111781,"median":-0.434072,"eighty":-0.268912,"marketCap":374681699},{"date":"2026-08-21","current":-11.23939,"twenty":-1.111781,"median":-0.434072,"eighty":-0.268912,"marketCap":358997349}],"updateTime":1787597798549},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PALI\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2647371482","title":"Palisade Bio Wins FDA IND Clearance for Pali-2108 Ulcerative Colitis Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2647371482","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647371482?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:31","pubTimestamp":1782736272,"startTime":"0","endTime":"0","summary":"Palisade Bio wins FDA IND clearance for PALI-2108 ulcerative colitis trialPalisade Bio won FDA clearance of an IND for PALI-2108, enabling a global Phase 2 ulcerative colitis study.ASCENTRA-UC targets","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL9BFJ2r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4588","SG9999014039.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","SG9999014013.SGD","SG9999014021.USD","BK4112","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00BKPKM429.USD","NDAQ","LU2210150020.SGD","BK4139","LU2095319765.USD","PALI","SG9999014005.SGD","BK4585","IE00B3QW5Z07.USD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647937116","title":"Palisade Bio - Ascentra-uc Enrollment Expected H2 2026; Primary Efficacy Results Expected H2 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2647937116","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647937116?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:30","pubTimestamp":1782736200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nTUA3DR2TB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PALI","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647711623","title":"Palisade Bio - Expects to Submit Ind for Ascentra-cd in Crohn's Disease in H2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2647711623","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647711623?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:30","pubTimestamp":1782736200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nTUA3DR2TB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PALI","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647371902","title":"Palisade Bio Receives FDA Clearance of Ind for Pali-2108 and Plans to Initiate Global Phase 2 Ascentra-uc Study in Ulcerative Colitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2647371902","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647371902?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:30","pubTimestamp":1782736200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nTUA3DR2TB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PALI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647371167","title":"Palisade Bio - Ascentra-uc Phase 2 Trial to Enroll up to 204 Patients in North America and Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2647371167","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647371167?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:30","pubTimestamp":1782736200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nTUA3DR2TB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PALI","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644366430","title":"Palisade Bio director Robert Baltera Jr. files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2644366430","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644366430?lang=en_us&edition=fundamental","pubTime":"2026-06-19 04:06","pubTimestamp":1781813161,"startTime":"0","endTime":"0","summary":"Palisade Bio director Robert Baltera Jr. filed an initial Form 3 with the SEC dated June 10, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palisade Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL4X2kVg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PALI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643121631","title":"Palisade Bio director Jordan Michael Zwick files initial beneficial ownership statement (Form 3)","url":"https://stock-news.laohu8.com/highlight/detail?id=2643121631","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643121631?lang=en_us&edition=fundamental","pubTime":"2026-06-13 08:08","pubTimestamp":1781309294,"startTime":"0","endTime":"0","summary":"Palisade Bio director Jordan Michael Zwick filed an initial Form 3 with the SEC dated June 10.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palisade Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 12, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260613:nNDLb7Swp6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PALI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642232187","title":"Palisade Bio raises authorized common shares to 450 million from 300 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2642232187","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642232187?lang=en_us&edition=fundamental","pubTime":"2026-06-12 05:24","pubTimestamp":1781213055,"startTime":"0","endTime":"0","summary":"Palisade Bio shareholders backed a charter amendment to lift authorized common stock to 450,000,000 shares from 300,000,000 at June 10, 2026 meeting.The amendment was filed in Delaware on June 11, 2026, becoming effective immediately.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palisade Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 11, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDL7C9sP6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PALI","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642284087","title":"Palisade Bio adds Robert Baltera, Jordan Zwick to board of directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2642284087","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642284087?lang=en_us&edition=fundamental","pubTime":"2026-06-11 20:45","pubTimestamp":1781181922,"startTime":"0","endTime":"0","summary":"Palisade Bio added Robert Baltera, senior advisor at Frazier Life Sciences, to its board as it advances PALI-2108 toward Phase 2.Baltera previously led Amira Pharmaceuticals as CEO before its 2011 sale to Bristol-Myers Squibb for USD 475 million.Jordan Zwick, co-founder and chief business officer of Mirador Therapeutics, also joined the board.Zwick previously held senior business development and strategy roles at Amarin and InflaRx, with earlier experience at Medtronic.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDL3VT5QG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0070302665.USD","IE00BQXX3F31.USD","LU2125154778.USD","IE00BJT1NW94.SGD","IE0009355771.USD","LU2468319806.SGD","LU0211331839.USD","LU1323610961.USD","BK4581","IFRX","LU1032466523.USD","BK4585","IE00BGHQF631.EUR","LU2210149790.SGD","IE00BJJMRZ35.SGD","LU1430594728.SGD","LU1261432733.SGD","LU1093756168.USD","LU1244550577.SGD","LU1061106388.HKD","BK4588","LU1074936037.SGD","LU0432979614.USD","LU0211326755.USD","IE00B64PRP62.GBP","AMRN","LU2089283258.USD","LU2242652126.USD","BMY","LU1670711040.USD","BK4533","LU0306807586.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU0882574055.USD","NDAQ","LU1868837300.USD","LU0211326839.USD","LU1023059063.AUD","LU2111349929.HKD","LU0006306889.USD","LU1868837136.USD","LU0106261372.USD","LU0496365809.HKD","LU0158827948.USD","LU0321505439.SGD","LU0985481810.HKD","MDT","PALI","LU2271345857.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642604144","title":"Palisade Bio to Present on the Potential of PALI-2108 for Fibrostenotic Crohn’s Disease at New York Academy of Sciences Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2642604144","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642604144?lang=en_us&edition=fundamental","pubTime":"2026-06-09 20:45","pubTimestamp":1781009100,"startTime":"0","endTime":"0","summary":"Presentation to highlight fibrostenotic Crohn’s disease biology and the potential of a locally bioactivated PDE4 inhibitor prodrug approach Denver, CO, June  09, 2026  (GLOBE NEWSWIRE) -- Palisade Bio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/09/3308858/0/en/Palisade-Bio-to-Present-on-the-Potential-of-PALI-2108-for-Fibrostenotic-Crohn-s-Disease-at-New-York-Academy-of-Sciences-Symposium.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","PALI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640194303","title":"Palisade Bio (PALI) Gets a Buy from B. Riley Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2640194303","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640194303?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:58","pubTimestamp":1780405131,"startTime":"0","endTime":"0","summary":"In a report released today, William Wood from B. Riley Securities reiterated a Buy rating on Palisade Bio, with a price target of $7.00. According ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/palisade-bio-pali-gets-a-buy-from-b-riley-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/palisade-bio-pali-gets-a-buy-from-b-riley-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PALI","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635783097","title":"Analysts Are Bullish on These Healthcare Stocks: BridgeBio Pharma (BBIO), Palisade Bio (PALI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635783097","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635783097?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:40","pubTimestamp":1778668831,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on BridgeBio Pharma (BBIO), Palisade Bio (PALI) and Coy...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-bridgebio-pharma-bbio-palisade-bio-pali-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-bridgebio-pharma-bbio-palisade-bio-pali-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4112","BK4139","BK4581","BK4007","BLSG","BLSX","LU0029874061.USD","BBIO","BK4137","PALI","LU0128526141.USD","BK4585","LABU","XBI","BK4588","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635230562","title":"Palisade Bio Inc - May Offer and Sell up to $300 Mln of Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2635230562","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635230562?lang=en_us&edition=fundamental","pubTime":"2026-05-13 05:28","pubTimestamp":1778621303,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nFWN41P1MG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PALI","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635238852","title":"Palisade Bio Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635238852","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635238852?lang=en_us&edition=fundamental","pubTime":"2026-05-13 05:01","pubTimestamp":1778619713,"startTime":"0","endTime":"0","summary":"Palisade Bio Inc reports results for the quarter ended March 31 - Earnings SummaryPalisade Bio Inc PALI.OQ reported a quarterly adjusted loss of 5 cents per share for the quarter ended March 31, highe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL8N41P37A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PALI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635240439","title":"Palisade Bio Q1 EPS $(0.05) Misses $(0.04) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635240439","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635240439?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:27","pubTimestamp":1778617669,"startTime":"0","endTime":"0","summary":"Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.04) by 25 percent. This is a 89.36 percent increase over losses of $(0.47) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52507382/palisade-bio-q1-eps-0-05-misses-0-04-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Palisade Bio Q1 EPS $(0.05) Misses $(0.04) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","PALI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635240106","title":"Palisade Bio Q1 net loss widens on higher R&D costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2635240106","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635240106?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:26","pubTimestamp":1778617594,"startTime":"0","endTime":"0","summary":"Palisade Bio Q1 net loss widens on higher R&D costsOverviewUS biopharma firm's Q1 net loss widened on higher R&D and administrative expensesCompany advanced PALI-2108 with positive Phase 1b data; Phas","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL1N41P1EY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PALI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635345240","title":"Palisade Bio plans Phase 2 ulcerative colitis trial of PALI-2108 in Q3 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2635345240","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635345240?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:18","pubTimestamp":1778617119,"startTime":"0","endTime":"0","summary":"Palisade Bio set a Phase 2 ulcerative colitis trial for PALI-2108 to start in Q3 2026, with an IND filing expected in Q2 2026.Results have already been presented from Phase 1a/1b studies, including a Phase 1b fibrostenotic Crohn’s disease cohort, supporting advancement into mid-stage development.Program showed favorable safety and tolerability, with evidence of drug activity in intestinal tissue and early signals of clinical benefit in Crohn’s disease, without reporting technical performance figures.Phase 2 ulcerative colitis primary efficacy results are expected in 2H 2027; Phase 2 Crohn’s disease trial start is targeted for Q1 2027 with a readout expected early 2028.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palisade Bio Inc. pu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL8FJMJn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","PALI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635247097","title":"BRIEF-Palisade Bio Q1 EPS USD -0.05","url":"https://stock-news.laohu8.com/highlight/detail?id=2635247097","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635247097?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:15","pubTimestamp":1778616945,"startTime":"0","endTime":"0","summary":"BRIEF-Palisade Bio Q1 EPS USD -0.05\n\n\nMay 12 (Reuters) - Palisade Bio Q1 operating expenses USD 10.748 million.\n\nQ1 operating income USD -10.748 million\nQ1 net income USD -9.6 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nPLXAEDA00:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","PALI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635247048","title":"Palisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of Pali-2108","url":"https://stock-news.laohu8.com/highlight/detail?id=2635247048","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635247048?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:15","pubTimestamp":1778616901,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUA1QT3W8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PALI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635069247","title":"Palisade Bio Q1 Operating Expenses USD 10.748 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635069247","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635069247?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:15","pubTimestamp":1778616900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nPLXAEDA00:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","PALI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":69,"code":"91000000","status":"200"}]}}